Is anyone making bonus on Kyprolis?

[anonymous]

Was there a mass departure in oncology recently? Got calls rom 2 recruiters for the same position, said there were openings across the country selling Kyprolis.

Burning buikding

 

[anonymous]

Was there a mass departure in oncology recently? Got calls rom 2 recruiters for the same position, said there were openings across the country selling Kyprolis.

Great drug but crazy goals = zero bonus and reps quitting

 

[anonymous]

LAURA BRAND WANTS YOU ALL TO QUIT SO SHE CAN HIRE EXPERIENCED BCG CONSULTANTS TO SELL KYPROLIS. THEY WILL ALL PUT YOU REPS TO SHAME!

 

[anonymous]

the funny thing is that us Kyprolis reps making zero bonus can now work 10 hrs a week like blue/orange reps- why even try?
Sad thing is that it is hurting patients-

 

[anonymous]

the funny thing is that us Kyprolis reps making zero bonus can now work 10 hrs a week like blue/orange reps- why even try?
Sad thing is that it is hurting patients-

This why we Orange and Blue will get your product you lazy bums. We will show you how to dominate in oncology.

 

[anonymous]

This why we Orange and Blue will get your product you lazy bums. We will show you how to dominate in oncology.

Really, why didn't you do that with Vectibix and T-Vec. The Onyx folks actually outsold the Amgen territories with Vectibix. Oh you thought we forgot about that didn't you. Amgen OBU = primary care losers.

 

[anonymous]

nobody is making goal and all the onyx reps are gone. Left with Amgen retreads and new folks who weren't selling elsewhere. 1/1/17 is layoffs and brining krypolis into the fold with the other products.

 

[anonymous]

Who made these goals? They're reduced from S1? Yeah right. Whole districts won't make any money this S? Do they want everyone to quit? Wth? Was this ZS or internal poor goal setting?

and guess what we on the Neulasta side are getting our S1 goals adjusted so that we make money! look who Amgen really cares about. We are the ones to make money and work 4 hours a day!!!!!

 

[anonymous]

and guess what we on the Neulasta side are getting our S1 goals adjusted so that we make money! look who Amgen really cares about. We are the ones to make money and work 4 hours a day!!!!!

Dummy...we're all Amgen now. There are almost no legacy Onyx reps left.

 

[anonymous]

Dummy...we're all Amgen now. There are almost no legacy Onyx reps left.

They don't get it

 

[anonymous]

I am having so much fun talking about cardiac and aneurysm side effects with Kyprolis. With no bonus and unatrainable goals, what else is their to talk about! Ha!! F U Amgen!!

 

[anonymous]

I am having so much fun talking about cardiac and aneurysm side effects with Kyprolis. With no bonus and unatrainable goals, what else is their to talk about! Ha!! F U Amgen!!

I do the same too. I am waiting for another Clovis build up. I heard Array Biopharma will be looking soon too. I am going to FUCK Kyprolis by talking about the safety considerations but will forget about efficacy.

 

[anonymous]

I do the same too. I am waiting for another Clovis build up. I heard Array Biopharma will be looking soon too. I am going to FUCK Kyprolis by talking about the safety considerations but will forget about efficacy.

I am my way out by working only a few hours a day. When I do go out I talk about the safety issues of kyprolis but never mention the overall
Survival benefit. In fact some of my doctors have switched patients back to velcade or to Ninlaro. Darzelex is killing it and the rep told me they are hiring in territory. It may be big pharma but at least I get paid and the drug is better than kyprolis. F Amgen!

 

[anonymous]

I am my way out by working only a few hours a day. When I do go out I talk about the safety issues of kyprolis but never mention the overall
Survival benefit. In fact some of my doctors have switched patients back to velcade or to Ninlaro. Darzelex is killing it and the rep told me they are hiring in territory. It may be big pharma but at least I get paid and the drug is better than kyprolis. F Amgen!

Let's see how Brian Heath and Laura Brand try and motivate me. Laura will replace us with fancy MBAs with no oncology Doctor relationships. Watch the brand just die.

 

[anonymous]

To all my fellow Onyx people left and those new Amgen Kyprolis reps that are not hitting goal or making money. I hereby declare the week of September 6th, national cardiac and aneurysm week for Kyprolis. Let's freakin' kill this brand and get the heck out of here. Please pledge that you will only speak of the warning letter and cardiac this week and no efficacy at all! Who is with me?

 

[Brian Heath]

To all my fellow Onyx people left and those new Amgen Kyprolis reps that are not hitting goal or making money. I hereby declare the week of September 6th, national cardiac and aneurysm week for Kyprolis. Let's freakin' kill this brand and get the heck out of here. Please pledge that you will only speak of the warning letter and cardiac this week and no efficacy at all! Who is with me?

Try this and I will have Amgen Repata or Enbrel reps replacing you. F with my bonus, I will F with your employment.

 

[anonymous]

We the Repatha reps would gladly take kyprolis. At least it has some access.

 

[anonymous]

We the Repatha reps would gladly take kyprolis. At least it has some access.

HAHAHA Amgen's plan is to throw PCP reps on it's only therapeutic oncology product! No one Amgen OBU is the biggest joke.

Repatha reps can't sell in CV and now they think they can walk into oncology. What a joke.

 

[anonymous]

So are they adjusting quotas or what? Funny we don't even have official numbers yet but we all know we're screwed

 

[anonymous]

So are they adjusting quotas or what? Funny we don't even have official numbers yet but we all know we're screwed

No adjustments. Amgen wants to keep quota high to get rid of the low performing reps. Amgen needs kyprolis to grow so quota will not be adjusted. Amgen also does not want to payout reps for trying. They want reps who exceed quota. They are willing to transfer reps from other BUs to oncology to fill the void and give them a crack at hitting the target quota.